Dan Peer
21Patents
3h-index
18Co-inventors
60Inventor score
Filing activity: Sep 10, 2001 → Dec 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7544374B2 | Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy | Human Necessities | 9 | Expired |
| US10583084B2 | Liposomal formulations for delivery of nucleic acids | Chemistry; Metallurgy | 4 | Active |
| US9526705B2 | Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy | Human Necessities | 3 | Active |
| US9574210B2 | Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US8277847B2 | Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy | Human Necessities | 3 | Active |
| US10920246B2 | Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes | Chemistry; Metallurgy | 3 | Active |
| US9259474B2 | Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy | Human Necessities | 3 | Active |
| US12065664B2 | Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles | Chemistry; Metallurgy | 1 | Active |
| US11851389B2 | Cationic lipids for nucleic acid delivery and preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US9421172B2 | Lipidated glycoprotein particles and methods of use | Human Necessities | 0 | Active |
| US11338042B2 | Immunoparticles and methods of generating and using same | Chemistry; Metallurgy | 0 | Active |
| US9925143B2 | Lipidated glycosaminoglycan particles for the delivery of nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US8178129B2 | Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy | Human Necessities | 0 | Active |
| US12403114B2 | Cannabinoid acid ester compositions and uses thereof | Human Necessities | 0 | Active |
| US10543278B2 | Immunoparticles and methods of generating and using same | Chemistry; Metallurgy | 0 | Active |
| US8808664B2 | Lipidated glycoprotein particles and methods of use | Human Necessities | 0 | Active |
| US8501237B2 | Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy | Human Necessities | 0 | Active |
| US11708421B2 | Modular platform for targeted therapeutics | Chemistry; Metallurgy | 0 | Active |
| US10179113B2 | Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US6630454B2 | Method and pharmaceutical composition for the treatment of cancer | Human Necessities | 0 | Expired |
| US9566346B2 | Positively charged polysaccharides for RNA transfection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.